Completed Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment NCT04874948 Conditions Actinomycetales Infections, Bacterial Infections, Bacterial Infections Respiratory, +9 more Locations PRA Health Sciences (PRA) - Early Development Services (EDS) — Groningen, Netherlands View Trial Details
